Locations:
Search IconSearch

Cancer

nci-vol-9189-150_650x450

Gene Profile Test Holds Predictive Potential for Early Stage Melanoma Patients

Test helpful for SLN-negative, stage I to IIA and thin tumors

19-LRI-043_CQD_Eng-PTEN-variant_650x450

FDA Recognizes PTEN Variant Criteria

Earlier detection of certain cancers a likely result

19-LRI-044_Cheng-personal-mutanomes_CQD_650x450

Personal Mutanomes, Precision Oncology and Drug Discovery

Toward detailed, personalized maps of identified and interpreted genomic variation

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

amyloid_650x450
January 15, 2019/Cancer/Research

New Chemotherapy Regimen Proves Effective in Treating Amyloidosis

Refractory patients respond to combination therapy

Researchers in lab

New Grants Boost Hereditary Breast and Ovarian Cancer Research

Understanding resistance in PARP inhibitor therapy

nci-vol-10540-650×450
December 27, 2018/Cancer/Research

Molecular Profiling Improves Progression-Free Survival in Patients with Pancreatic Cancer

Know Your Tumor initiative matches treatments with patients

BackPage 68 of 87Next

Advertisement

Ad